|
|
[½»Á÷]
Ö¬·¾ÒÆÖ²×¨Ì⣺ÄÉÃ×Ö¬·¾ÒÆÖ²
Ö¬·¾ÒÆÖ²×¨Ì⣺ÄÉÃ×Ö¬·¾ÒÆÖ²
×÷Õß¼ò½é£ºÖ£ÑÒ£¬ÉϺ£½»Í¨´óѧҽѧԺÁÙ´²Ò½Ñ§²©Ê¿ºó£¬µÚËľüÒ½´óѧÍâ¿ÆÑ§Ò½Ñ§²©Ê¿£¬Ê×½ìÖйúÑо¿ÐÍҽԺѧ»áÕûÐÎÍâ¿ÆÑ§×¨ÒµÎ¯Ô±»áίԱ£¬Aesthetic Plastic SurgeryÔÓÖ¾Éó¸åÈË£¬Ä¿Ç°¾ÍÖ°ÓÚËÄ´¨»ªÃÀ×ÏܰҽѧÃÀÈÝÒ½Ôº¡£
ÎÄÏ×À´Ô´£º
1. Tonnard P, Verpaele A, Peeters G, et al. Nanofat grafting: basic research and clinical applications[J]. Plast Reconstr Surg. 2013 Oct; 132(4): 1017-1026.
2. Lo Furno D, Tamburino S, Mannino G, et al. NANOFAT 2.0: experimental evidence for a fat grafting rich in mesenchymal stem cells[J]. Physiol Res. 2017 Apr 12. [Epub ahead of print].
¹Ø¼ü´Ê£ºÄÉÃ×Ö¬·¾£»Ö¬·¾ÒÆÖ²£»Ã沿ÄêÇữ£»Ö¬·¾¸Éϸ°û
ÄÚÈݾ«Ñ¡£º
¡°ÄÉÃ×Ö¬·¾ÒÆÖ²¡±£¨nanofat grafting£©¿ÉÒÔ˵ÊÇÖ¬·¾ÒÆÖ²ÁìÓò×îÐÂ×îÈÈÃŵÄÒÆÖ²¼¼Êõ£¬ÓɱÈÀûʱ²¼Â³Èû¶û´óѧҽԺÕûÐÎÍâ¿ÆPatrick TonnardµÈÊ×Ïȱ¨µÀ¡£ËùνÄÉÃ×£ºÊÇÓ¢ÎÄnanoµÄÒôÒ룬1 ¦Ìm=1000 nm£¬ÄÉÃײÄÁϵÄÖ±¾¶ÔÚ0.1¡«100 nmµÄ·¶Î§ÄÚ¡£¶øËùνµÄ¡°ÄÉÃ×Ö¬·¾¡±ÖÐÖ¬·¾Ï¸°ûÖ±¾¶´óÔ¼ÔÚ10 ¦Ìm×óÓÒ£¬Òò´Ë¡°ÄÉÃ×Ö¬·¾¡±µÄÃüÃû²¢²»×¼È·¡£
Ö¬·¾ÒÆÖ²¼¼ÊõÔÚÕûÐÎÍâ¿ÆÁÙ´²Ó¦ÓÃÀúÊ·ÓÆ¾Ã£¬°´ÕÕÒÆÖ²Ö¬·¾Ìå»ý´óС¿É·ÖΪ£º£¨1£©´óÖ¬·¾ÍÅÒÆÖ²£¨macrofat grafting£©£º³£¹æµÄÖ¬·¾³éÎüºÍÖ¬·¾ÒÆÖ²£»£¨2£©Ï¸Ð¡Ö¬·¾ÍÅÒÆÖ²£¨microfat grafting£©£ºÓöà¿×µÄϸСÎü¹Ü³éÎüÖ¬·¾½øÐÐÒÆÖ²µÄ·½·¨£»£¨3£©ÄÉÃ×Ö¬·¾ÒÆÖ²£¨nanofat grafting£©£º ϸС֬·¾¾»úеÐÔÈ黯ºó£¬Æä¹ýÂ˺óµÄÒºÌåΪÄÉÃ×Ö¬·¾¡£
1. ÄÉÃ×Ö¬·¾ÖƱ¸
ÄÉÃ×Ö¬·¾È黯¹ý³Ì£º´ø¶à²à¿Úϸ¹Ü³éÎüºóµÄÖ¬·¾¾Æ¯Ï´£¨¼ûͼ 1ºÍ2£©£¬ÔÚÁ½¸ö10ml×¢ÉäÆ÷ͨ¹ýÌØÊâת»»Í·£¨ÖдøÂËÍø£©À´»ØÍÆÀ£¬30´ÎºóÖ¬·¾È黯ºóÔÙ¾500 ¦Ìm¿×¾¶ÄáÁú²¼ÁϹýÂ˺óµÃµ½ÄÉÃ×Ö¬·¾£¨¼ûͼ 3£©¡£
ͼ1 ϸ¹Ü³éÖ¬ÕëÍ·£¨±ê×¼Ì׹ܺͶà²à¿ÚÌ׹ܣ©
ͼ2Ö¬·¾³éÎüÎï
ͼ3ÄÉÃ×Ö¬·¾ÖƱ¸£ºÈ黯¹ý³Ì
ͨ¹ýÓ«¹âȾɫ¼ì²âÖ¬·¾»îÐÔ£¬½á¹ûÏÔʾ£º£¨1£©´óÖ¬·¾ÍÅ×飨3ºÁÃ׹ܾ¶±ê×¼Ì׹ܣ©Ö¬·¾´æ»îÁ¼ºÃ£»£¨2£©Ï¸Ð¡Ö¬·¾ÍÅ×飨3ºÁÃ׹ܾ¶¶à¿ÚÌ׹ܣ©Ö¬·¾´æ»îÁ¼ºÃ£»£¨3£©ÄÉÃ×Ö¬·¾×飨3ºÁÃ׹ܾ¶¶à¿ÚÌ׹ܣ¬¾È黯¹ý³Ì£©Ö¬·¾Ï¸°ûºÍÕý³£µÄÖ¬·¾×éÖ¯½á¹¹½ÏÉÙ£¬¼ûͼ 4¡£
ͼ4Ó«¹âȾɫ¼ì²âÖ¬·¾»îÐÔ
£¨A: ´óÖ¬·¾ÍÅ£»B£ºÏ¸Ð¡Ö¬·¾ÍÅ£»C£ºÄÉÃ×Ö¬·¾×é¡£
ÂÌɫӫ¹â´ú±í»îϸ°û£¬ºìɫӫ¹â´ú±íËÀϸ°û£©
2. ÄÉÃ×Ö¬·¾ÔÚÃæ²¿ÄêÇữÖеÄÁÙ´²Ó¦ÓÃ
2010Äê5Ôµ½2012Äê 9ÔÂPatrick TonnardµÈ²ÉÓÃÄÉÃ×Ö¬·¾¶Ô67Àý»¼Õß½øÐÐÁËÃæ²¿ÄêÇữµÄÖÎÁÆ£¬Ð§¹û½ÏºÃ£º£¨1£©¿ÚÖÜÄêÇữ38Àý£¬56.7 %£»£¨2£©Ã¼¼äÄêÇữ15Àý£¬22.4%£»£¨3£©Èé¹µÈÕ¹âËðÉËÆ¤·ô8Àý£¬11.9%£»£¨4£©ñ£ºÛ4Àý£¬6.0%£»£¨5£©ºÚÑÛȦ2Àý£¬3.0%¡£¾ßÌå·½·¨Îª£ºÖƱ¸ÄÉÃ×Ö¬·¾£¬Ò»°ã²ÉÓÃ27G×¢ÉäÕëͷƤÄÚ+ƤÏÂ×¢É䣬ÖÁƤ·ô³ÊÏÖµ»ÆÉ«¸Ä±ä¡£ÊõºóÖð½¥ÏÔЧ£¬ÔÚ4-6¸öÔÂʱ´ïµ½×î¼ÑЧ¹û£¬ÎÞ¸ÐȾ¡¢Ö¬·¾ÄÒÖס¢ÈâÑ¿Ö×µÈÃ÷ÏԵIJ¢·¢Ö¢£¬´óÃæ»ý×¢Éäʱ»á³öÏÖºì°ß£¬1-2ÌìºóÏûʧ¡£
3. ÁÙ´²²¡Àý
3.1 Case 1£ºÅ®£¬41Ë꣬µÍÐØVÁìÇøÉÈÐÎÖåÎÆ£¬¸øÓè×ÝÏò×¢ÉäÖ¬·¾£¬6 mlϸС֬·¾ÖåÎÆÆ¤ÄÚ×¢É䣨23G£©+ 12 mlÄÉÃ×Ö¬·¾VÁìÇøÕæÆ¤ÏÂdz²ã×¢É䣨27G£©£¬ÖåÎÆÃ÷ÏÔ¼õÇᣬ¼ûͼ 5¡£
3.2 Case 2£ºÅ®£¬33Ë꣬ÑÛ´ü+ºÚÑÛȦ£¬¸øÓèÑÛ´üÕû¸´Êõ£¨Íâ·¡¢¿ôÔµÊÍ·Å·¨£©+ 1.6ml/²àÄÉÃ×Ö¬·¾Æ¤ÄÚ×¢É䣬ÊõºóƤ·ô³öѪ»ÆÈ¾£¬1¸öÔºóÏûʧ£¬ºì°ß3¸öÔºóÏûʧ£¬¼ûͼ 6¡£
3.3 Case 3£ºÅ®£¬61Ë꣬¿ÚÖÜÖåÎÆ£¬¸øÒÔ4mlϸС֬·¾ÖåÎÆÆ¤ÄÚ×¢É䣨23GÈñÕ룩+6mlÄÉÃ×Ö¬·¾¿ÚÖÜÆ¤ÄÚ×¢É䣬¿ÚÖÜÖåÎÆÃ÷ÏØ¼õÇᣬ¼ûͼ 7¡£
4. ÌÖÂÛ
ϸС֬·¾Ìî³äÒ»°ãʹÓÃÖ±¾¶0.7-0.9mmµÄ¶ÛÕ룬ΪÁË×¢Éäʱ˳³©£¬Ö¬·¾¿ÅÁ£ÐèÒª×㹻С£¬Òò´Ë³éÖ¬¹ÜÐèÒª×㹻С¡£ÏÂíúÌî³äÐèÓÃÖ±¾¶2mm²à¿×1mmµÄ³éÖ¬¹Ü£¬19G×¢Ö¬Õë¡£Ãæ²¿ÆäËüµØ·½ÓÃÖ±¾¶3mm²à¿×2mm¹Ü¡£
¸ÃÎÄ×÷ÕßÓÃ27G×¢Ö¬ÕëÌî³äÃæ²¿Ç³±íÖåÎÆ£¬µ«ÊÇÒòΪ֬·¾Ï¸°ûÔÚÈ黯¹ý³ÌÖб»ÆÆ»µ£¬Ìî³äЧ¹û²¢²»ÀíÏ룬µ«×¢ÉäÇøÆ¤·ôÖʵرäºÃ£¬Òò´ËÖªµÀÄÉÃ×Ö¬·¾¿ÉÒÔ¸ÄÉÆÆ¤·ôÖʵأ¬Æä×÷Óñ»ÈÏΪÊÇÀ´Ô´ÓÚÖ¬·¾¸Éϸ°û£¨adipose-derived mesenchymal stem cells, ASCs£©¡£ASCs´æÔÚÓÚÖ¬·¾×éÖ¯ÖеÄѪ¹Ü»ùÖʳɷݣ¨stromal vascular fraction, SVF£©ÖУ¬¾ßÓжàÏò·Ö»¯Ç±ÄÜ£¬ÄÜ·ÖÃÚ¶àÖÖÉú³¤Òò×Ó¡£
ÄÉÃ×Ö¬·¾ÒÆÖ²Êµ¼ÊÆðÖ÷Òª×÷ÓõÄÊÇASCs£¬Òò´Ë×îºÃÊÇÄÜÈ¥³ýËÀÍöµÄÖ¬·¾Ï¸°û£¬µÃµ½´¿»¯µÄSVF£¬µ«ÊÇÕâ¸ö¹ý³ÌºÄʱ·ÑÇ®£¬ÁíÍ⻵ËÀµÄÖ¬·¾Ï¸°ûÊͷŵÄÉú³¤Òò×Ó¶ÔÃæ²¿ÄêÇữҲÓÐ×÷Óᣱ¾Ñо¿Ö¤ÊµÄÉÃ×Ö¬·¾ÖдæÔÚ´óÁ¿¾ßÓлîÐÔµÄASCs£¬µ«ÊÇÏà¶ÔÖ¬·¾³éÎüÎïÖÐASCsÀ´Ëµ»¹ÊÇÌ«ÉÙ£¬Lo Furno D µÈ±¨µÀÁËÒ»ÖÖʹÄÉÃ×Ö¬·¾ÖеÄASCsÊýÁ¿Ã÷ÏÔÌá¸ßµÄÌáÈ¡·½·¨£¬ËûÃdzÆÎª¡°nanofat 2.0¡±¡£
ÄÉÃ×Ö¬·¾ÒÆÖ²²»ÄÜÆðµ½Ìî³äµÄ×÷Óã¬ÒòΪÄÉÃ×Ö¬·¾ÖÐ×éÖ¯ºÍÖ¬·¾Ï¸°ûÆÆ»µÃ÷ÏÔ£¬Ö»ÓÃÓÚ¸ÄÉÆÆ¤·ôÖʵأ¬ÏÔЧÐèÒª1-3¸öÔº󡣺ÚÑÛȦÊõºó»á´æÔڽϳ¤Ê±¼äµÄºì°ß£¬¿ÉÄÜÊÇÓÉÓÚ×éÖ¯ÐÞ¸´½á¹¹ÖØÅÅ¡£
½áÂÛ£ºÄÉÃ×Ö¬·¾ÒÆÖ²ÊÊÓÃÓÚ¸ÄÉÆÆ¤·ôÖʵء£
5. ±ÊÕ߯ÀÂÛ
Coleman SRµÄ×ÔÌåÖ¬·¾ÒÆÖ²¼¼ÊõÊÇÈí×éÖ¯Ìî³äµÄ±ê×¼·½·¨ £¬ÓÃÍâ¾¶3 mm¡¢²à¿×ÄÚ¾¶2 mmµÄÕëÍ·ÎüÖ¬£¬ÓôóÕëÍ·×¢É䣬ÕâÖÖ·½·¨ÌáÈ¡µÄÖ¬·¾²»ÄÜÓÃÓÚϸÕëÍ·½øÐÐÆ¤ÏÂ×¢Éä¡£TrepsatµÄ΢֬·¾ÒÆÖ²¼¼ÊõÔò²ÉÓÃÍâ¾¶2 mm¡¢²à¿×1 mmµÄÎüÖ¬Õë¡£NguyenÓÿ׾¶600¦Ìm¶à¿×ÎüÖ¬Õ룬25 GÕëÍ·£¨ÄÚ¾¶260 ¦Ìm£©½øÐÐ×¢Éä¡£ÊÊÓÃÓÚdz±íºÍƤÏÂ×¢Éä¡£Tonnard PµÈ½«Ö¬·¾»úеÈ黯ºó£¬Óÿ׾¶Æ½¾ùΪ500 ¦ÌmµÄÄáÁú²¼¹ýÂ˵ÄÌáÈ¡Îï³ÆÎª¡°ÄÉÃ×Ö¬·¾¡±£¬²¢ÓÃ27 GÕëÍ·×¢É䣨ÄÚ¾¶210 ¦Ìm£©£¬Òò³ÆÎªÄÉÃ×Ö¬·¾£¬µ«È´ÊÇ΢Ã×¼¶µÄ£¬ËùÒÔÎÒÃÇÈÏΪ½Ð×ö³¬Î¢Ö¬·¾ÒÆÖ²¸üºÏÊÊ£¬¼´¿ÉÒÔÇø±ðÓÚ΢֬·¾ÒÆÖ²¡£
ÀíÏëµÄÖ¬·¾ÒÆÖ²Ö±¾¶²»Ó¦¸Ã³¬¹ý3mm¡£ÎÒÃÇÔÚÁÙ´²Ê¹ÓÃ3ÖÖ²»Í¬µÄ¼¼Êõ»ñȡ֬·¾£¬µÚ1ÖÖ·½·¨Í¨¹ýColeman²å¹Ü£¬Ëù»ñµÃµÄÖ¬·¾Ð¡Ò¶³¤¶ÈΪ2.2¡«7.3 mm¡£µÚ2ÖÖ·½·¨Í¨¹ý1mm¿ª¿ÚµÄ²å¹Ü£¬Ëù»ñµÃµÄÖ¬·¾Ð¡Ò¶³¤¶ÈΪ3.17¡«6.4 mm¡£µÚ3ÖÖ·½·¨Í¨¹ý3 mmµÄColeman²å¹Ü£¬²¢ÓÃÎÒÃǵÄÉ豸½«ÆäÇÐË飬Ëù»ñµÃµÄÖ¬·¾Ð¡Ò¶³¤¶ÈΪ2.6¡«3.05 mm¡£ÓÃø´Ù·¨²â¶¨ÒÔÉÏ3ÖÖ·½·¨µÄ´æ»îÂÊ£¬½á¹ûÏàËÆ¡£¸Ã½á¹û±íÃ÷£¬ÇÐËéÖ¬·¾×éÖ¯¿ÉÒÔÌṩ´óСһÖµÄÖ¬·¾Î¢Á££¬²¢Î¬³ÖÆä»îÁ¦¡£
£¨¹ÜÀíÔ±qingfengzjhÉóУ£©
×î½üÒ»¶Îʱ¼äÓÉÓÚ¹¤×÷½Ï棬ûÓм°Ê±ÍÆËÍÕûÐÎÃÀÈݵÄÇ°ÑØ½øÕ¹£¬Ôڴ˸ø¸÷λÌýÖÚÖÂÒÔ³ÏÖ¿µÄǸÒâ¡£³ýÁ˶ÔÕûÐÎÃÀÈÝÊÂÒµ¼«´óÐËȤ֮Í⣬´ó¼ÒµÄ¹Ø×¢¡¢ÊÕÌý¡¢½»Á÷¡¢×ª·¢ºÍÍÆ¹ã£¬Ò²ÊÇÎÒÃÇÖÂÁ¦ÓÚÕûÐÎÃÀÈÝÊÂÒµµÄ¾«Éñ¶¯Á¦Ö®Ô´¡£
Èç¹û¾õµÃÄÚÈÝÓеãÒâ˼£¬ÇëÌí¼Ó΢ÐŹ«ÖںţºÕûÐÎÃÀÈÝɳÁú£¬»òÕßɨÃè¶þάÂëÌí¼Ó¡£»¶Ó¸÷λͬÐлý¼«²ÎÓëͶ¸å£¬ÆÀÂÛ£¬½¨ÒéµÈ£¬Í¨¹ý·ÖÏíÕûÐÎÃÀÈÝÐÐÒµµÄм¼ÊõнøÕ¹Ð¹۵㣬´Ù½øÕûÐÎÃÀÈÝѧÊõ·±ÈÙ£¬ÒµÎñ¾«½ø¡£
¡°ÕûÐÎÃÀÈÝɳÁú¡±ÉÏ·¢±íµÄËùÓÐÎÄÕ£¬Î´¾ÔÊÐí²»µÃ×ªÔØ£¬ÈçÏ£Íû×ªÔØ£¬ÇëÁªÏµ¹ÜÀíÔ±£¬Çë¸÷΢ÐŹ«Öںš¢ÍøÕ¾¼°¿Í»§¶Ë×ðÖØ±¾¹«ÖںŰæÈ¨£¬¾ÔÊÐí¿É×ªÔØÎÄÕÂʱÇëÇå³þ×¢Ã÷À´Ô´ÎªÕûÐÎÃÀÈÝɳÁú¹«Öںţ¬»¶ÓÄúת·¢ÅóÓÑȦ¡£
![Ö¬·¾ÒÆÖ²×¨Ì⣺ÄÉÃ×Ö¬·¾ÒÆÖ²]()
1ϸ¹Ü³éÖ¬ÕëÍ·.jpg
![Ö¬·¾ÒÆÖ²×¨Ì⣺ÄÉÃ×Ö¬·¾ÒÆÖ²-1]()
2È黯ǰ֬·¾.jpg
![Ö¬·¾ÒÆÖ²×¨Ì⣺ÄÉÃ×Ö¬·¾ÒÆÖ²-2]()
3È黯¹ý³Ì.jpg
![Ö¬·¾ÒÆÖ²×¨Ì⣺ÄÉÃ×Ö¬·¾ÒÆÖ²-3]()
4Ó«¹â¼ì²â²»Í¬Ìå»ýÖ¬·¾»îÐÔ.jpg
![Ö¬·¾ÒÆÖ²×¨Ì⣺ÄÉÃ×Ö¬·¾ÒÆÖ²-4]()
5.jpg
![Ö¬·¾ÒÆÖ²×¨Ì⣺ÄÉÃ×Ö¬·¾ÒÆÖ²-5]()
6ÏÂíúƤ·ôËɳÚ+Àá¹µ.jpg
![Ö¬·¾ÒÆÖ²×¨Ì⣺ÄÉÃ×Ö¬·¾ÒÆÖ²-6]()
7¿ÚÖÜÖåÎÆ.jpg
[ Last edited by silicare on 2017-7-19 at 11:41 ] |
|